Plasma levels and antidepressive effect of imipramine. 1976

L F Gram, and N Reisby, and I Ibsen, and A Nagy, and S J Dencker, and P Bech, and G O Petersen, and J Christiansen

The relationship between the antidepressive effect of imipramine and the plasma concentrations of imipramine and the active metabolite desipramine was studied in 24 patients suffering from endogenous depression. After a placebo period of 7 days, the patients received imipramine, 75 mg 3 times a day. The dose was reduced in patients with pronounced side effects. Blood samples for drug assay were drawn in the morning, 15 hr after the last drug intake. Imipramine and desipramine in plasma were assayed by quantitative in situ thin-layer chromatography. Individual variations in plasma concentration were 20- to 30-fold in both imipramine and desipramine. Severity of depression was assessed on the Hamilton Rating Scale (HRS). Eleven of 12 patients who responded satisfactorily to the treatment (HRS post-treatment score less than 8) had plasma concentration of imipramine greater than or equal to 45 mug/L, and desipramine greater than 75 mug/L, whereas the 12 patients not responding satisfactorily (post-treatment score on HRS greater than or equal to 8) all had concentrations of imipramine or desipramine or both below these limits.

UI MeSH Term Description Entries
D007099 Imipramine The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group. Imidobenzyle,Imizin,4,4'-Methylenebis(3-hydroxy-2-naphthoic acid)-3-(10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)-N,N-dimethyl-1-propanamine (1:2),Imipramine Hydrochloride,Imipramine Monohydrochloride,Imipramine Pamoate,Janimine,Melipramine,Norchlorimipramine,Pryleugan,Tofranil
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D003891 Desipramine A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors. Desmethylimipramine,Apo-Desipramine,Demethylimipramine,Desipramine Hydrochloride,Norpramin,Novo-Desipramine,Nu-Desipramine,PMS-Desipramine,Pertofran,Pertofrane,Pertrofran,Petylyl,Ratio-Desipramine,Apo Desipramine,Hydrochloride, Desipramine,Novo Desipramine,Nu Desipramine,PMS Desipramine,Ratio Desipramine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

L F Gram, and N Reisby, and I Ibsen, and A Nagy, and S J Dencker, and P Bech, and G O Petersen, and J Christiansen
January 1985, Neuropsychobiology,
L F Gram, and N Reisby, and I Ibsen, and A Nagy, and S J Dencker, and P Bech, and G O Petersen, and J Christiansen
December 1959, La Riforma medica,
L F Gram, and N Reisby, and I Ibsen, and A Nagy, and S J Dencker, and P Bech, and G O Petersen, and J Christiansen
December 1975, La Clinica terapeutica,
L F Gram, and N Reisby, and I Ibsen, and A Nagy, and S J Dencker, and P Bech, and G O Petersen, and J Christiansen
October 1975, Psychopharmacology bulletin,
L F Gram, and N Reisby, and I Ibsen, and A Nagy, and S J Dencker, and P Bech, and G O Petersen, and J Christiansen
October 1974, Diseases of the nervous system,
L F Gram, and N Reisby, and I Ibsen, and A Nagy, and S J Dencker, and P Bech, and G O Petersen, and J Christiansen
March 1971, Proceedings of the Royal Society of Medicine,
L F Gram, and N Reisby, and I Ibsen, and A Nagy, and S J Dencker, and P Bech, and G O Petersen, and J Christiansen
July 1961, Science (New York, N.Y.),
L F Gram, and N Reisby, and I Ibsen, and A Nagy, and S J Dencker, and P Bech, and G O Petersen, and J Christiansen
September 1976, Archives of general psychiatry,
L F Gram, and N Reisby, and I Ibsen, and A Nagy, and S J Dencker, and P Bech, and G O Petersen, and J Christiansen
February 1967, The British journal of psychiatry : the journal of mental science,
L F Gram, and N Reisby, and I Ibsen, and A Nagy, and S J Dencker, and P Bech, and G O Petersen, and J Christiansen
August 1963, Psychopharmacologia,
Copied contents to your clipboard!